Showing results (411-420 of 617) with videos related to

Sort By:
Pageof 62
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
Gynecologic Oncology|March 16, 2007
Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group studyVictoria Champion, Stephen D Williams, Anna Miller, et al.
Gynecologic Oncology|January 1, 1997
Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancerA R Munkarah, A V Hallum, M Morris, et al.
Gynecologic Oncology|March 13, 2012
Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneumDavid M Gershenson, Charlotte C Sun, Revathy B Iyer, et al.
American Journal of Obstetrics and Gynecology|July 1, 1997
Molecular profile of advanced-stage transitional cell carcinoma of the ovaryD M Gershenson, V V Baker, J E Price, et al.
Gynecologic Oncology|February 19, 2014
Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovarySatoshi Takeuchi, Martin Lucchini, Kathleen M Schmeler, et al.
Gynecologic Oncology|July 6, 2011
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinomaErin R King, Zhifei Zu, Yvonne T M Tsang, et al.
Gynecologic Oncology|December 25, 2007
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneumKathleen M Schmeler, Charlotte C Sun, Diane C Bodurka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?Pamela T Soliman, Russell R Broaddus, Kathleen M Schmeler, et al.
Pageof 62